Skip to main content

stock

CGON · CG Oncology, Inc.

What CG Oncology, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live CGON price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on CGON.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
88,640,375 as of 2026-08-05 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-4056.2%
Net
-3602.8%

Returns

ROE
-21.8%
ROA
-20.7%

Health

Current ratio
22.2x
Debt/equity
0.0x

Deep value

NCAV
$993.11M
NCAV per share
$11.20
Price/NCAV
Locked
NNWC
-$36.40M
NNWC per share
-$0.41
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$1.16M—Gross profit: unreported by this company.-$86.40M-$79.06M
10-Q filed 2026-08-06
2026-03-31$1.08M—Gross profit: unreported by this company.-$66.39M-$60.20M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$2.32M—Gross profit: unreported by this company.-$48.70M-$41.31M
DEF 14A filed 2026-04-24
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$1.67M—Gross profit: unreported by this company.-$51.13M-$43.81M
10-Q filed 2025-11-14
2025-06-30$0—Gross profit: unreported by this company.-$48.74M-$41.43M
10-Q filed 2026-08-06
2025-03-31$52,000—Gross profit: unreported by this company.-$42.20M-$34.45M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$456,000—Gross profit: unreported by this company.-$38.05M-$31.80M
DEF 14A filed 2026-04-24
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$43,000—Gross profit: unreported by this company.-$28.30M-$20.41M
10-Q filed 2025-11-14
Assets
$1.09B
Equity
$1.03B

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$4.04M-$190.77M-$161.00M-$132.48M
2024-12-31$1.14M-$114.67M-$88.04M-$78.95M
2023-12-31$204,000-$55.45M-$48.61M—

Company filings

2 offering filings in 12 months · since Thu Aug 6

events

  • Results, Other event

    ResultsOther event
    Aug 68-K
  • Shareholder vote results

    Shareholder vote results
    Jun 88-K
  • Executive or director change

    Executive or director change
    May 268-K
  • Results

    Results
    May 88-K
  • Executive or director change

    Executive or director change
    Apr 138-K
  • Results

    Results
    Feb 278-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • POST LEONARD E

    Director

    Sale$72,980

    Sep 17, 4:30 PM ET

  • POST LEONARD E

    Director

    Sale$74,540

    Aug 18, 4:30 PM ET

  • POST LEONARD E

    Director

    Sale$71,170

    Jul 17, 4:15 PM ET

  • Mulay James

    Director

    Sale$1,816,241

    Jul 14, 4:15 PM ET

All insider trades for CGON

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

  • Point72

    Calls · Period Tue 30 Jun 2026

    0.0%Trimmed

All funds

News

Stories that named CGON, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about CGON.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about CGON.

nakagai

Signals on CGON come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the CGON board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

CG Oncology, Inc. (CGON): SEC filings, financials and insider trades · Nakagai